<SEC-DOCUMENT>0001193125-22-272455.txt : 20221213
<SEC-HEADER>0001193125-22-272455.hdr.sgml : 20221213
<ACCEPTANCE-DATETIME>20221028160202
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-22-272455
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20221028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Edwards Lifesciences Corp
		CENTRAL INDEX KEY:			0001099800
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				364316614
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9492502500

	MAIL ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDWARDS LIFESCIENCES CORP.
		DATE OF NAME CHANGE:	20090225

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDWARDS LIFESCIENCES CORP
		DATE OF NAME CHANGE:	20000203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVG CONTROLLED INC
		DATE OF NAME CHANGE:	19991126
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g387605g1027222118448.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">October&nbsp;28, 2022 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>VIA EDGAR </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities&nbsp;&amp; Exchange
Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, NE
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mail Stop 3561 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Attn:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amanda Ravitz </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Barbara Jacobs </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>RE:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Edwards Lifesciences Corp </B></P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>Definitive Proxy Statement on Schedule 14A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>Filed March&nbsp;22, 2022 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>File <FONT STYLE="white-space:nowrap">No.&nbsp;001-15525</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Mses. Ravitz and Jacobs, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Edwards Lifesciences
Corporation (which we refer to as &#147;we&#148; or the &#147;Company&#148;), this letter sets forth the Company&#146;s responses to the comments of the staff of the Securities and Exchange Commission (the &#147;Staff&#148;) set forth in your letter
dated September&nbsp;22, 2022, regarding the Company&#146;s above-referenced Definitive Proxy Statement on Schedule 14A. For your convenience, each of the Staff&#146;s comments precedes the Company&#146;s response. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Definitive Proxy Statement on Schedule 14A filed March&nbsp;22, 2022 </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>General </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>1.</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Please expand your discussion to explain how the experience of your Lead Independent Director is brought to
bear in connection with your board&#146;s role in risk oversight. </I></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Response: </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We acknowledge the Staff&#146;s comment and will enhance the discussion in the Company&#146;s next annual proxy statement in accordance with the Staff&#146;s
comment. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>2.</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Please expand upon the role that your Lead Independent Director plays in the leadership of the board. For
example, please enhance your disclosure to address whether or not your Lead Independent Director may: </I></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>represent the board in communications with shareholders and other stakeholders;</I> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>require board consideration of, and/or override your CEO on, any risk matters; or</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>provide input on design of the board itself.</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Response: </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We acknowledge the Staff&#146;s comment
and will enhance the discussion in the Company&#146;s next annual proxy statement in accordance with the Staff&#146;s comment. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>3.</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Please expand upon how your board administers its risk oversight function. For example, please disclose:
</I></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>the timeframe over which you evaluate risks (e.g., short-term, intermediate-term, or long-term) and how you
apply different oversight standards based upon the immediacy of the risk assessed; </I></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>whether you consult with outside advisors and experts to anticipate future threats and trends, and how often
you <FONT STYLE="white-space:nowrap">re-assess</FONT> your risk environment;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>how the board interacts with management to address existing risks and identify significant emerging risks;</I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>whether you have a Chief Compliance Officer and to whom this position reports; and</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>how your risk oversight process aligns with your disclosure controls and procedures.</I>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Response: </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We acknowledge
the Staff&#146;s comment and will enhance the discussion in the Company&#146;s next annual proxy statement in accordance with the Staff&#146;s comment. As requested by the Staff in its letter, we also confirm that we will address in the
Company&#146;s next annual proxy statement any material developments to the Company&#146;s risk oversight structure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">******** </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you have any questions regarding the foregoing, please contact the undersigned by phone at (949) <FONT STYLE="white-space:nowrap">250-5911</FONT> or by
email at linda_park@edwards.com. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sincerely,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Linda J. Park</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Linda J. Park</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Associate General
Counsel</P></TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Michael A. Mussallem, Chairman and Chief Executive Officer </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Arnold Pinkston, Corporate Vice President, General Counsel </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g387605g1027222118448.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g387605g1027222118448.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !P %4# 2(  A$! Q$!_\0
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MX!Q[UB>!_$<GBSPC8ZW+;K;O=>9^Z5]P4*[*.>_W:+(+L=_PAFE^MQ_WW_\
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'[_3 * /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
